Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Urinal Forte Probio
- Development stage
- Unknown
- Lead developer
- Walmark
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Urinal Forte Probio is an over-the-counter (OTC) dietary supplement developed by Walmark (a subsidiary of STADA) and distributed by Vivapharm. It is formulated as oral capsules designed to support urinary tract health and prevent recurrent urinary tract infections (UTIs). The supplement combines two active components: PACran, a patented whole cranberry (Vaccinium macrocarpon) powder rich in proanthocyanidins (PACs), and the probiotic bacterium Lactobacillus rhamnosus. Cranberry proanthocyanidins exert an anti-adhesive effect by binding to the fimbriae of uropathogenic Escherichia coli, preventing their attachment to the uroepithelial walls of the bladder and urethra, thereby facilitating their clearance through urination. Lactobacillus rhamnosus helps restore and maintain a healthy microflora, competing with pathogenic bacteria for adhesion sites and producing antimicrobial substances like lactic acid and bacteriocins, particularly after antibiotic therapy.
- Brand names
- Urinal Forte Probio
- Other names
- Walmark Urinal Forte Probio
Beyond the preview
Go deeper on Urinal Forte Probio.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Urinal Forte Probio.